Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 118,000 | 57,000 | -85,000 | 173,000 | 117,000 |
| Depreciation Amortization | 12,000 | 6,000 | 21,000 | 17,000 | 11,000 |
| Accounts receivable | -8,000 | 7,000 | -21,000 | 2,000 | 3,000 |
| Accounts payable and accrued liabilities | 60,000 | 30,000 | -98,000 | -75,000 | -29,000 |
| Other Working Capital | -147,000 | -62,000 | 125,000 | -122,000 | -134,000 |
| Other Operating Activity | -90,000 | -74,000 | 54,000 | 19,000 | -16,000 |
| Operating Cash Flow | $-55,000 | $-36,000 | $-4,000 | $14,000 | $-48,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,000 | -33,000 | -245,000 | -233,000 | -171,000 |
| PPE Investments | -126,000 | -125,000 | -5,000 | -4,000 | -2,000 |
| Sale Of Investment | 64,000 | 36,000 | 27,000 | 15,000 | 10,000 |
| Purchase Sale Intangibles | -5,000 | -5,000 | N/A | 1,000 | 1,000 |
| Other Investing Activity | -5,000 | -5,000 | 0 | 1,000 | 1,000 |
| Investing Cash Flow | $-103,000 | $-127,000 | $-223,000 | $-221,000 | $-162,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,000 | -11,000 | -3,000 | -2,000 | -1,000 |
| Common Stock Issued | 2,000 | 2,000 | 2,000 | 2,000 | N/A |
| Common Stock Repurchased | -11,000 | -11,000 | -90,000 | -66,000 | -29,000 |
| Other Financing Activity | -4,000 | -2,000 | -9,000 | -6,000 | -4,000 |
| Financing Cash Flow | $-24,000 | $-22,000 | $-100,000 | $-72,000 | $-34,000 |
| Exchange Rate Effect | N/A | -1,000 | -1,000 | -2,000 | -1,000 |
| Beginning Cash Position | 774,000 | 774,000 | 1,102,000 | 1,102,000 | 1,102,000 |
| End Cash Position | 592,000 | 588,000 | 774,000 | 821,000 | 857,000 |
| Net Cash Flow | $-182,000 | $-186,000 | $-328,000 | $-281,000 | $-245,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,000 | -36,000 | -4,000 | 14,000 | -48,000 |
| Capital Expenditure | -126,000 | -125,000 | -5,000 | -4,000 | -2,000 |
| Free Cash Flow | -181,000 | -161,000 | -9,000 | 10,000 | -50,000 |